Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Found 1904 publications
Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate, Liver), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA), Product (Instruments, Software),... US$ 5,650.00

... liquid biopsy market on the basis of cancer type, circulating biomarkers, end users, products & services, and regions. Based on cancer type, the market is segmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, liver cancer, and other cancers (melanoma, bladder cancer, and ovarian cancer). Based on circulating biomarkers, the liquid biopsy market ...

Jul, 2016 161 pages
Cancer Diagnostics Market Players--Strategic Assessments of Major Suppliers and Emerging Market Entrants US$ 2,500.00

... .com provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market ...

Jul, 2016 80 pages
Global Cancer Immunotoxins Market & Clinical Pipeline Insight 2020 US$ 2,400.00

... Immunotoxins to Multiple Cancer Therapies Global Cancer Immunotoxins Market Future Prospects Global Cancer Immunotoxins Clinical Pipeline by Company, Indication & Phase Global Cancer Immunotoxins Clinical Pipeline: 52 Cancer Immunotoxins Majority Cancer Immunotoxins ...

Jul, 2016 240 pages
Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021) (By Type: Imaging Tests, Endoscopy, Biopsy, Tumor Marker; By Imaging Tests Sub-Type: MRI, Ultrasound,... US$ 2,400.00

... resulted in the growth of global cancer diagnostics market Market for cancer diagnostics is growing at a steady pace due to higher incidences of cancer among the population, where emerging markets are expected to achieve ... report, Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021), Global Cancer Diagnostics market is projected to exhibit a CAGR of over ~8.8% during 2016 - 2021. On the basis of market segment, Global Cancer Diagnostics Market has been ...

Jul, 2016 132 pages
Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics US$ 4,995.00

Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics Summary Urological cancers ...

Jun, 2016 143 pages
Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis US$ 9,495.00

Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis Summary GlobalData estimates that the ... and CAR-T therapies. Revenue by indications for major IO products in 2019 and 2024. Key topics covered include strategic competitor assessment, market characterization ...

May, 2016 423 pages
Breast Cancer Screening (Mammography, MRI and Ultrasound) Market and Population Forecast to 2021 - Global Analysis US$ 1,850.00

... the other top contributors to the global breast cancer screening population. iGATE RESEARCH report titled “Breast Cancer Screening (Mammography, MRI and Ultrasound) Market and Population Forecast to 2021 ... Breast Cancer Screening Population, Market and Forecast 2. Breast Cancer Mammography Screening Population and Forecast 3. Breast Cancer MRI and Ultrasound Screening Population and Forecast 4. Breast Cancer Mammography Screening Market and Forecast 5. Breast Cancer MRI Screening Market and Forec

Jul, 2016 510 pages
Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies US$ 6,995.00

Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies Summary Hematological malignancies are a class of cancer ...

Jun, 2016 73 pages
Cancer Diagnostics: US, Europe, Japan-Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers US$ 34,750.00

... in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Asia; ... Japan, Spain, UK, USA Worldwide Market Overview Five-year test volume and sales projections by country. Comprehensive market segmentation analysis, including review of the market ...

Jun, 2016 1200 pages
Spain Cancer Diagnostics Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers US$ 6,800.00

... analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Spanish cancer diagnostics markets; reviews ... . Market Segmentation Analysis Sales and market shares of major suppliers, by individual cancer diagnostic test. Five-year test volume and sales forecasts for major cancer diagnostic tests by market ...

Jun, 2016 565 pages
Cancer Diagnostic Instrumentation and Strategic Profiles of Leading Suppliers US$ 3,850.00

This 119-page report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing.

Jun, 2016 119 pages
Cancer Diagnostic Tests, and Strategic Profile of Leading Reagent and Instrument Suppliers US$ 3,850.00

... , as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth ...

Jun, 2016 286 pages
Cancer Diagnostics: US, Europe, Japan--Country Segment Volume and Sales Forecasts, Laboratory Universe US$ 2,850.00

... cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer ...

Jun, 2016 11 pages
Cancer Diagnostic Test Volume and Sales Forecasts by Country US$ 2,450.00

... cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and ...

Jun, 2016 11 pages
Cancer Diagnostics: Major Suppliers Strategic Assessments US$ 2,500.00

This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution ...

Jun, 2016 80 pages
Cancer Diagnostics: Profiles of Leading Suppliers US$ 2,500.00

This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 80 pages

Jun, 2016 80 pages
Cancer Diagnostics Market: Strategic Assessments of Current and Emerging Competitors US$ 2,500.00

... .com provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market ...

Jul, 2016 80 pages
Cancer Diagnostic Technologies and Strategic Profiles of Leading Suppliers US$ 3,850.00

... technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics ...

Jun, 2016 185 pages
Cancer Diagnostics Market: Sales Forecasts by Country, Strategic Profiles of Leading Suppliers, Emerging Tests, Innovative Technologies, Instrumentation Review US$ 7,500.00

... global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: Estimated numbers of cancer testing ... volume and sales forecasts for France, Germany, Italy, Japan, Spain, U.K. and U.S. Marketing and technological assessment, as well as medical rationale and diagnostic prospects for ...

Jul, 2016 510 pages
Next Generation Cancer Diagnostics Market Size & Forecast By Technology (DNA & Protein Microarrays, Lab-on-a-chip, RT-PCR & Multiplexing, & NGS Sequencing), By Function (Risk Analysis,... US$ 4,700.00

Global next generation cancer diagnostics market is anticipated to reach USD 20.25 billion by 2022 growing at an estimated CAGR of 32.0% from ... rendering driver in this region. Key players contributing significantly to the next generation cancer diagnostics market are Novartis AG, Cepheid, Roche Holdings AG, Perkin Elmer Inc., Sysmex ...

Feb, 2016 75 pages
Genomics In Cancer Care Market Analysis By Product (Instruments, Consumables, Services), By Application (Diagnostics, Personalized Medicine, Drug Discovery & Development, Research), By... US$ 4,700.00

Global genomics in cancer care market is expected to reach USD 9.22 billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer coupled with adoption ... cancer are responsible for the potential growth of genomics in cancer care. Further key findings from the study suggest: Instrument segment dominated the overall market ...

Feb, 2016 80 pages
Ovarian Cancer-Pipeline Insights, 2016 US$ 2,250.00

... pipeline assets across the Ovarian Cancer. The Report gives insights on 225+ products. It also includes around 185+ companies which are active in this field. DelveInsight’s, Ovarian Cancer -Pipeline Insights, 2016 Report covers the pipeline ...

Jul, 2016 260 pages
Ovarian Cancer - Treatment Landscape & Competitive Analysis, 2016 US$ 2,450.00

... treatment, development partner, patent expiry date, sales data etc. Comparative analysis of marketed drugs by therapy, cost of treatment and Therapeutic Class. Coverage of the Ovarian Cancer Phase III and Pre-registration Drugs Analysis ...

Jul, 2016 90 pages
Ovarian Cancer - Market Insights, Epidemiology and Market Forecast-2020-US US$ 3,250.00

... forecasted epidemiological data for the diagnosed incident cases of Ovarian Cancer from 2012-2020. According to DelveInsight, the forecasted patient population of Ovarian cancer will decrease at a CAGR of 0.54% from 2012 to 2020 and the worldwide Ovarian cancer market ...

Jul, 2016 60 pages
Estrogen Receptor Positive (ER+) Breast Cancer-Pipeline Insights, 2016 US$ 1,750.00

... Estrogen Receptor Positive (ER+) Breast Cancer. These days’ companies are focusing on the Targeted Therapy for cancer. Ipsen’s Triptorelin pamoate ...

Jul, 2016 179 pages
Estrogen Receptor Positive (ER+) Breast Cancer - Treatment Landscape & Competitive Analysis, 2016 US$ 2,450.00

... cost of treatment, development partner, patent expiry date, sales data etc. Comparative analysis of marketed drugs by therapy, cost of treatment, Therapeutic Class. Coverage of the Estrogen Receptor Positive (ER+) Breast Cancer Phase III and Pre-registration Drugs Analysis ...

Jul, 2016 90 pages
Estrogen Receptor Positive (ER+) Breast Cancer - Market Insights, Epidemiology and Market Forecast-2023_United States US$ 3,250.00

... incident cases of Estrogen Receptor Positive (ER+) Breast Cancer from 2013-2023. According to DelveInsight, the forecasted patient population of ER+ breast cancer will increase at a CAGR of 2.03% from 2015 to 2023 and the worldwide ER+ breast cancer market ...

Jul, 2016 60 pages
Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016' provides an overview of Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Non-Hodgkin Lymphoma. Report includes an overview of trial ...

May, 2016 2277 pages
Head And Neck Cancer Global Clinical Trials Review, H1, 2016 US$ 2,500.00

Head And Neck Cancer Global Clinical Trials Review, H1, 2016 SUMMARY GlobalData's clinical trial report, “Head And Neck Cancer Global Clinical Trials Review, H1, 2016' provides an overview of Head And Neck Cancer clinical trials ...

May, 2016 1597 pages
Vulvar Cancer - Pipeline Review, H1 2016 US$ 2,000.00

Vulvar Cancer - Pipeline Review, H1 2016 SUMMARY Global Markets Direct’s, ‘Vulvar Cancer - Pipeline Review, H1 2016’, provides an overview of the Vulvar Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Vulvar Cancer ...

May, 2016 73 pages
Global Cancer Diagnostics Device Market 2016-2020 US$ 2,500.00

... of the global cancer diagnostics devices market for 2016-2020 To calculate the market size, we consider revenue generated from the sales of molecular and companion cancer diagnostic devices. The market is divided into the following segments based on geography: Americas APAC EMEA Technavio's report, Global Cancer Diagnostics Devices Market 2016-2020, has ...

Jun, 2016 67 pages
Lung Cancer Diagnostics Market Analysis By Type (Small Cell Lung Cancer, Non-small Cell Lung Cancer), By Test (Imaging Test, Biopsy, Sputum Cytology, Molecular Testing), And Segment... US$ 4,700.00

... development of lung cancer-specific biomarkers is one of the primary factors for the growth of the lung cancer diagnostics market over the forecast period. These diagnostic tools facilitate the personalized treatment approach of lung malignancies. Various biomarkers are ...

Mar, 2013 94 pages
Vaginal Cancer Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Vaginal Cancer Global Clinical Trials Review, H1, 2016' provides an overview of Vaginal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Vaginal Cancer. Report includes an overview of trial ...

May, 2016 79 pages
Uterine Cancer Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Uterine Cancer Global Clinical Trials Review, H1, 2016' provides an overview of Uterine Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Uterine Cancer. Report includes an overview of trial ...

May, 2016 942 pages
Thyroid Cancer Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Thyroid Cancer Global Clinical Trials Review, H1, 2016' provides an overview of Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Thyroid Cancer. Report includes an overview of trial ...

May, 2016 320 pages
Thymus Cancer Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Thymus Cancer Global Clinical Trials Review, H1, 2016' provides an overview of Thymus Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Thymus Cancer. Report includes an overview of trial ...

May, 2016 90 pages
Testicular Cancer Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Testicular Cancer Global Clinical Trials Review, H1, 2016' provides an overview of Testicular Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Testicular Cancer. Report includes an overview of trial ...

May, 2016 147 pages
Peritoneal Cancer Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Peritoneal Cancer Global Clinical Trials Review, H1, 2016' provides an overview of Peritoneal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Peritoneal Cancer. Report includes an overview of trial ...

May, 2016 802 pages
Ovarian Cancer Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H1, 2016' provides an overview of Ovarian Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Ovarian Cancer. Report includes an overview of trial ...

May, 2016 1725 pages
Laryngeal Cancer Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Laryngeal Cancer Global Clinical Trials Review, H1, 2016' provides an overview of Laryngeal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Laryngeal Cancer. Report includes an overview of trial ...

May, 2016 277 pages
Gastric Cancer Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Gastric Cancer Global Clinical Trials Review, H1, 2016' provides an overview of Gastric Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Gastric Cancer. Report includes an overview of trial ...

May, 2016 1350 pages
Gallbladder Cancer Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Gallbladder Cancer Global Clinical Trials Review, H1, 2016' provides an overview of Gallbladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Gallbladder Cancer. Report includes an overview of trial ...

May, 2016 189 pages
Fallopian Tube Cancer Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Fallopian Tube Cancer Global Clinical Trials Review, H1, 2016' provides an overview of Fallopian Tube Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Fallopian Tube Cancer. Report includes an overview of trial ...

May, 2016 698 pages
Esophageal Cancer Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Esophageal Cancer Global Clinical Trials Review, H1, 2016' provides an overview of Esophageal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Esophageal Cancer. Report includes an overview of trial ...

May, 2016 817 pages
Endometrial Cancer Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H1, 2016' provides an overview of Endometrial Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Endometrial Cancer. Report includes an overview of trial ...

May, 2016 444 pages
Cervical Cancer Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Cervical Cancer Global Clinical Trials Review, H1, 2016' provides an overview of Cervical Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical Cancer. Report includes an overview of trial ...

May, 2016 515 pages
Anal Cancer Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Anal Cancer Global Clinical Trials Review, H1, 2016' provides an overview of Anal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Anal Cancer. Report includes an overview of trial ...

May, 2016 109 pages
Vaginal Cancer - Pipeline Review, H1 2016 US$ 2,000.00

Vaginal Cancer - Pipeline Review, H1 2016 SUMMARY Global Markets Direct’s, ‘Vaginal Cancer - Pipeline Review, H1 2016’, provides an overview of the Vaginal Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Vaginal Cancer ...

May, 2016 72 pages
Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H1 2016 US$ 2,000.00

... Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H1 2016’, provides an overview of the Muscle Invasive Bladder Cancer (MIBC) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Muscle Invasive Bladder Cancer (MIBC ...

May, 2016 67 pages
Gallbladder Cancer - Pipeline Review, H1 2016 US$ 2,000.00

Gallbladder Cancer - Pipeline Review, H1 2016 SUMMARY Global Markets Direct’s, ‘Gallbladder Cancer - Pipeline Review, H1 2016’, provides an overview of the Gallbladder Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Gallbladder Cancer ...

May, 2016 64 pages
1 2 3 4 5 >
Skip to top